CRISPRclean RNA Depletion Panel (Insulin)

Focused RNA depletion panel for increasing detection sensitivity of low expressing transcripts in pancreatic tissues

CRISPRclean RNA depletion panel removes the highest expressing insulin transcripts in-vitro ahead of sequencing, redistributing sequencing clusters to unique biologically relevant transcripts —allowing you to maximize UMI and gene sensitivity.

Beyond ribodepletion, RNA samples typically have a small number of highly expressed, well characterized transcripts, and resequencing these transcripts adds little biologically relevant information. Unfortunately, these highly expressed transcripts outcompete low expressing transcripts for sequencing coverage. This lack of sequencing coverage coupled with significant noise from high expressing transcripts limits detection of low expressing genes, rare variants and unique fusion events that may be disease drivers.


  • Insulin panel designed to deplete overexpressing transcripts in pancreas samples
  • Re-assign sequencing reads to lower expressing transcripts for increased coverage​
  • Maximize variant and isoform detection with less sequencing


Catalog KIT1025
Samples per kit 24
Tissues evaluated in design Pancreas
Designed to deplete 2 insulin genes
CRISPRclean product compatibility Single cell (KIT1018) and ribodepletion (KIT1014)

CRISPRclean RNA Depletion Panel (Insulin)

24 samples

$1,200 Add to Cart

How can we boost your RNA-Seq research?

Schedule a Call

Connect with us to learn more.

For the US patent, the patent number is US 10,604,802 entitled Genome Fractioning. The patent publication is available here.

For the EP patent, the patent number is EP3102722 entitled Genome Fractioning. The patent publication is available here.